Phase II Study of LCL161 Alone and in Combination With Cyclophosphamide in Patients With Relapsed or Refractory Multiple Myeloma
Phase of Trial: Phase II
Latest Information Update: 09 Feb 2018
At a glance
- Drugs LCL 161 (Primary) ; Cyclophosphamide
- Indications Multiple myeloma
- Focus Therapeutic Use
- 09 Jan 2018 Status changed from recruiting to completed.
- 21 Mar 2017 Planned primary completion date changed from 1 Jan 2017 to 1 Jan 2018.
- 25 Aug 2016 Planned primary completion date changed from 1 Mar 2017 to 1 Jan 2017.